Apotea AB (publ) (CHIX:APOTES) Ending Cash Position: kr104 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
18 GF Score
Price kr65.20
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Ending Cash Position?

Apotea AB (publ) CHIX:APOTES 18 Ending Cash Position is kr104 Mil as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Ending Cash Position for the quarter that ended in Jun. 2026 was kr104 Mil.

Apotea AB (publ)'s quarterly Ending Cash Position increased from Dec. 2025 (kr31 Mil) to Mar. 2026 (kr105 Mil) but then declined from Mar. 2026 (kr105 Mil) to Jun. 2026 (kr104 Mil).

Apotea AB (publ)'s annual Ending Cash Position increased from Dec. 2023 (kr19 Mil) to Dec. 2024 (kr27 Mil) and increased from Dec. 2024 (kr27 Mil) to Dec. 2025 (kr31 Mil).

Apotea AB (publ) Ending Cash Position Related Terms

Apotea AB (publ) Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Ending Cash Position Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
81.70 18.20 19.10 27.30 30.60

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.00 97.70 30.60 104.70 103.50
CHIX:APOTES
18GF Score
Apotea AB (publ) CHIX:APOTES
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Apotea AB (publ)'s Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=27.3+3.3
=31

Apotea AB (publ)'s Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=104.7+-1.2
=104

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of kr104 Mil mean?
Apotea AB (publ) (CHIX:APOTES) has a Ending Cash Position of kr104 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Ending Cash Position too high?
Apotea AB (publ)'s current Ending Cash Position is kr104 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Ending Cash Position compare to competitors?
Apotea AB (publ)'s Ending Cash Position of kr104 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Ending Cash Position is kr104 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Ending Cash Position of kr104 Mil. The current Ending Cash Position is kr104 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Ending Cash Position is kr104 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for CHIX:APOTES

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr65.20
Price